Literature DB >> 28230651

Hypoxia Induces Internalization of κ-Opioid Receptor.

Chunhua Xi1, Xuan Liang, Chunhua Chen, Hasan Babazada, Tianzuo Li, Renyu Liu.   

Abstract

BACKGROUND: It has been demonstrated that κ-opioid receptor agonists can reduce hypoxia-ischemia brain injury in animal models. However, it is unclear how the κ-opioid receptor responds to hypoxia-ischemia. In the current study, the authors used an in vitro model of oxygen-glucose deprivation and reoxygenation to explore how κ-opioid receptors respond to hypoxia and reoxygenation.
METHODS: Mouse neuroblastoma Neuro2A cells were stably transfected with mouse κ-opioid receptor-tdTomato fusion protein or Flag-tagged mouse κ-opioid receptor, divided into several groups (n = 6 to 12), and used to investigate the κ-opioid receptor movement. Observations were performed under normal oxygen, at 30 min to 1 h after oxygen-glucose deprivation and at 1 h after reoxygenation using high-resolution imaging techniques including immunoelectronmicroscopy in the presence and absence of κ-opioid receptor antagonist, dynamin inhibitors, potassium channel blockers, and dopamine receptor inhibitor.
RESULTS: Hypoxic conditions caused the κ-opioid receptor to be internalized into the cells. Inhibition of dynamin by Dyngo-4a prevented the receptor internalization. Interestingly, a specific κ-opioid receptor antagonist norbinaltorphimine blocked internalization, suggesting the involvement of activation of a specific κ-opioid receptor. κ-Opioid receptor internalization appears to be reversed by reoxygenation. Quantities of intracellular κ-opioid receptor-associated gold particles as demonstrated by immunoelectron microscopy were increased from 37 to 85% (P < 0.01) after oxygen-glucose deprivation. Potassium channel blockers and dopamine receptor inhibitor failed to block hypoxia-induced κ-opioid receptor internalization.
CONCLUSIONS: Hypoxia induces reversible κ-opioid receptor internalization, which was inhibited by selective κ-opioid receptor antagonists or dynamin inhibitor, and can be reversed by reoxygenation in neuroblastoma cells, indicating the modulating effects between κ-opioid receptor and hypoxia via κ-opioid receptor activation and the dynamin-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28230651      PMCID: PMC5395330          DOI: 10.1097/ALN.0000000000001571

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  48 in total

1.  Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness.

Authors:  A Sood; S Salih; D Roh; L Lacharme-Lora; M Parry; B Hardiman; R Keehan; R Grummer; E Winterhager; P J Gokhale; P W Andrews; C Abbott; K Forbes; M Westwood; J D Aplin; E Ingham; I Papageorgiou; M Berry; J Liu; A D Dick; R J Garland; N Williams; R Singh; A K Simon; M Lewis; J Ham; L Roger; D M Baird; L A Crompton; M A Caldwell; H Swalwell; M Birch-Machin; G Lopez-Castejon; A Randall; H Lin; M-S Suleiman; W H Evans; R Newson; C P Case
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

2.  Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.

Authors:  Jeffrey S Smith; Abigail G Schindler; Emma Martinelli; Richard M Gustin; Michael R Bruchas; Charles Chavkin
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

3.  Modulation of the arrestin-clathrin interaction in cells. Characterization of beta-arrestin dominant-negative mutants.

Authors:  J G Krupnick; F Santini; A W Gagnon; J H Keen; J L Benovic
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

4.  The Role of κ Opioid Receptor in Brain Ischemia.

Authors:  Chunhua Chen; Chunhua Xi; Xuan Liang; Jingyuan Ma; Diansan Su; Ted Abel; Renyu Liu
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

Review 5.  Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis.

Authors:  Breann L Wolfe; JoAnn Trejo
Journal:  Traffic       Date:  2007-03-21       Impact factor: 6.215

6.  Hypoxia differentially regulates the mitogen- and stress-activated protein kinases. Role of Ca2+/CaM in the activation of MAPK and p38 gamma.

Authors:  P W Conrad; D E Millhorn; D Beitner-Johnson
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

7.  Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.

Authors:  Toru Goyagi; Thomas J K Toung; Jeffrey R Kirsch; Richard J Traystman; Raymond C Koehler; Patricia D Hurn; Anish Bhardwaj
Journal:  Stroke       Date:  2003-05-08       Impact factor: 7.914

8.  Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.

Authors:  Justine S Paradis; Stevenson Ly; Élodie Blondel-Tepaz; Jacob A Galan; Alexandre Beautrait; Mark G H Scott; Hervé Enslen; Stefano Marullo; Philippe P Roux; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 9.  Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia.

Authors:  M Fähling
Journal:  Acta Physiol (Oxf)       Date:  2008-09-01       Impact factor: 6.311

Review 10.  Agonist-induced regulation and trafficking of kappa opioid receptors.

Authors:  Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2004-06-18       Impact factor: 5.037

View more
  6 in total

1.  Protective effects of 7-hydroxyethyl chrysin on rats with exercise-induced fatigue in hypobaric hypoxia environment.

Authors:  Luwei Miao; Tong Zhao; Yingchun Gao; Linlin Jing; Qiong Huang; Huiping Ma
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-25

2.  Kappa opioid receptors internalization is protective against oxygen-glucose deprivation through β-arrestin activation and Akt-mediated signaling pathway.

Authors:  Jihong Xu; Fang Chen; Shuyan Wang; Nicholas S Akins; Md Imran Hossain; Yi Zhou; Jinxi Huang; Jiafu Ji; Jin Xi; Wenzhen Lin; John Grothusen; Hoang V Le; Renyu Liu
Journal:  Neurochem Int       Date:  2020-04-24       Impact factor: 3.921

3.  Molecular Interaction Between Butorphanol and κ-Opioid Receptor.

Authors:  Jiafu Ji; Wenzhen Lin; Amey Vrudhula; Jin Xi; Alexei Yeliseev; John R Grothusen; Weiming Bu; Renyu Liu
Journal:  Anesth Analg       Date:  2020-09       Impact factor: 6.627

4.  Neurons derived from human-induced pluripotent stem cells express mu and kappa opioid receptors.

Authors:  Zhi-Hai Ju; Xuan Liang; Yao-Yao Ren; Luo-Wa Shu; Yan-Hong Yan; Xu Cui
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

Review 5.  Technical Feasibility and Physiological Relevance of Hypoxic Cell Culture Models.

Authors:  Jiri Pavlacky; Jan Polak
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-21       Impact factor: 5.555

Review 6.  Opioids in cancer: The κ‑opioid receptor (Review).

Authors:  Qier Zhou; Zhiwei Zhang; Songkai Long; Wanjun Li; Baiyun Wang; Na Liang
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.